Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.
Soley Therapeutics has raised $200.0M in total funding. The most recent round was Series C. The last funding was announced in January 2026.
Soley Therapeutics's investors include Doug Leone Family Fund, HRTG Partners, Breyer Capital, Surveyor Capital, GordonMD Global Investments.
Soley Therapeutics is headquartered in San Francisco, United States.
Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.
Soley Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Soley Therapeutics — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/soley-therapeutics. Accessed July 31, 2026.
VCBacked. (2026). Soley Therapeutics — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/soley-therapeutics
{{cite web |title=Soley Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/soley-therapeutics |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated